NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug March 17, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by benzinga. Read more Source: https://www.benzinga.com/news/fda/26/03/51277695/nrx-pharma-stock-jumps-after-fda-signals-path-to-nda-for-ketamine-depression-drug
